HEMALASI ApS: Financial statements 2023
CVR: 42924016
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
HEMALASI ApS (CVR 42924016) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 443,482 and a net result of DKK 315,803 compared with DKK 425,841 the year before. Equity in the 2023 report amounted to DKK 571,644. The solvency ratio was 80.8%.
- Gross Profit
- DKK 443,482
- Profit/Loss
- DKK 315,803
- Equity
- DKK 571,644
- Total Assets
- DKK 707,575
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 443 t. | 316 t. | 572 t. | - |
| 2022 | - | - | 426 t. | 466 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
HEMALASI ApS has published its annual report for 2022. The net result was DKK 425,841.
About HEMALASI ApS
HEMALASI ApS is a Danish company of the type Anpartsselskab based in Hedensted, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Lars Zederkof. The company's owners include Helle Laursen, Lars Zederkof and Signe Forsberg Zederkof. In 2025, the company reported a gross profit of DKK 143,121 and a net result of DKK 71,105 compared with DKK 213,974 the year before. Equity in the 2025 report amounted to DKK 539,399.